XML 119 R101.htm IDEA: XBRL DOCUMENT v3.25.0.1
COMMITMENTS AND CONTINGENCIES - Narrative (Details)
$ in Thousands
 3 Months Ended 12 Months Ended
Jan. 15, 2025
USD ($)
Dec. 06, 2022
USD ($)
payment
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
liability
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Jan. 31, 2021
USD ($)
Dec. 31, 2019
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Payment for contingent consideration       $ 11,923 $ 0 $ 0    
Arkis                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration, cash payments due upon achievement of certain milestones               $ 25,500
Contingent consideration               13,100
Arkis | Milestone Payment One                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration, cash payments due upon achievement of certain milestones               10,000
Arkis | Milestone Payment Two                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration, cash payments due upon achievement of certain milestones               $ 15,500
Derma Sciences                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Number of liabilities | liability       1        
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)       $ 3,000        
Derma Sciences | BioD Earnout Payments and Medihoney Earnout Payments                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Payment for contingent consideration       $ 33,300        
ACell, Inc.                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Number of liabilities | liability       1        
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)             $ 23,900  
ACell, Inc. | Revenue-Based Performance Milestones In 2023                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)             $ 100,000  
Surgical Innovations Associates, Inc.                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration   $ 57,607            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)   $ 90,000            
Business acquisition, number of payments | payment   2            
Surgical Innovations Associates, Inc. | Revenue Based Performance Milestones                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration, cash payments due upon achievement of certain milestones   $ 32,600            
Payment for contingent consideration     $ 12,400          
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)   50,000            
Surgical Innovations Associates, Inc. | FDA Approval Of Premarket Approval                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Contingent consideration, cash payments due upon achievement of certain milestones   25,000            
Contingent consideration, cash payments due upon achievement of certain revenue-based performance milestones (up to)   $ 40,000            
Plainsboro, New Jersey Manufacturing Facility | Subsequent Event                
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]                
Purchase price of business acquisition $ 10,400